Lymphatic anomalies during lifetime in patients with Noonan syndrome: Retrospective cohort study

Noonan syndrome (NS) has been associated with an increased risk of lymphatic anomalies, with an estimated prevalence of 20%. The prevalence of lymphatic anomalies seems to differ between pathogenic variants. Therefore, this study aims to describe the clinical presentation, prevalence and genotype–ph...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of medical genetics. Part A 2022-11, Vol.188 (11), p.3242-3261
Hauptverfasser: Swarts, Jessie W., Kleimeier, Lotte E. R., Leenders, Erika K. S. M, Rinne, Tuula, Klein, Willemijn M., Draaisma, Jos M. T.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3261
container_issue 11
container_start_page 3242
container_title American journal of medical genetics. Part A
container_volume 188
creator Swarts, Jessie W.
Kleimeier, Lotte E. R.
Leenders, Erika K. S. M
Rinne, Tuula
Klein, Willemijn M.
Draaisma, Jos M. T.
description Noonan syndrome (NS) has been associated with an increased risk of lymphatic anomalies, with an estimated prevalence of 20%. The prevalence of lymphatic anomalies seems to differ between pathogenic variants. Therefore, this study aims to describe the clinical presentation, prevalence and genotype–phenotype correlations of lymphatic anomalies during life in patients with NS. This retrospective cohort study included patients (n = 115) who were clinically and genetically diagnosed with NS and visited the Noonan expertise Center of the Radboud University Medical Center between January 2015 and March 2021. Data on lymphatic anomalies during lifetime were obtained from medical records. Lymphatic anomalies most often presented as an increased nuchal translucency, chylothorax and/or lymphedema. Prenatal lymphatic anomalies increased the risk of lymphatic anomalies during infancy (OR 4.9, 95% CI 1.7–14.6). The lifetime prevalence of lymphatic anomalies was 37%. Genotype–phenotype correlations showed an especially high prevalence of lymphatic anomalies during infancy and childhood in patients with a pathogenic SOS2 variant (p = 0.03 and p 
doi_str_mv 10.1002/ajmg.a.62955
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9804719</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2703984387</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4575-173ea3d12cd2b5b96052a6b0521cdcaa82d2f6fd4f11482219c3e6c10f73b1133</originalsourceid><addsrcrecordid>eNp9kc1vFCEYh4nR2Np682xIvHhwVz4GmPFgsmnsh1k1MXpGBphdNjMwBabN_PfSbrtRD16AhCdP3t_7A-AVRkuMEHmvdsNmqZacNIw9AceYMbKoakqfHt6EHYEXKe0QoogJ_hwcUdaIhgt-DH6t52Hcquw0VD4Mqnc2QTNF5zewd53NbrDQeTgWxPqc4K3LW_g1BK88TLM3MQz2A_xucwxptDq7Gwt12IaYYcqTmU_Bs071yb58uE_Az_NPP84uF-tvF1dnq_VCV0ywBRbUKmow0Ya0rG04YkTxtpxYG61UTQzpeGeqDuOSiOBGU8s1Rp2gLcaUnoCPe-84tYM1ugwbVS_H6AYVZxmUk3__eLeVm3AjmxpVAjdF8PZBEMP1ZFOWg0va9r3yNkxJEoFoU1e0FgV98w-6C1P0JV6hCBEVJxUr1Ls9pctqUrTdYRiM5F118q46qeR9dQV__WeAA_zYVQGqPXDrejv_VyZXn79crPbe3-top7w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2722746245</pqid></control><display><type>article</type><title>Lymphatic anomalies during lifetime in patients with Noonan syndrome: Retrospective cohort study</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Swarts, Jessie W. ; Kleimeier, Lotte E. R. ; Leenders, Erika K. S. M ; Rinne, Tuula ; Klein, Willemijn M. ; Draaisma, Jos M. T.</creator><creatorcontrib>Swarts, Jessie W. ; Kleimeier, Lotte E. R. ; Leenders, Erika K. S. M ; Rinne, Tuula ; Klein, Willemijn M. ; Draaisma, Jos M. T.</creatorcontrib><description>Noonan syndrome (NS) has been associated with an increased risk of lymphatic anomalies, with an estimated prevalence of 20%. The prevalence of lymphatic anomalies seems to differ between pathogenic variants. Therefore, this study aims to describe the clinical presentation, prevalence and genotype–phenotype correlations of lymphatic anomalies during life in patients with NS. This retrospective cohort study included patients (n = 115) who were clinically and genetically diagnosed with NS and visited the Noonan expertise Center of the Radboud University Medical Center between January 2015 and March 2021. Data on lymphatic anomalies during lifetime were obtained from medical records. Lymphatic anomalies most often presented as an increased nuchal translucency, chylothorax and/or lymphedema. Prenatal lymphatic anomalies increased the risk of lymphatic anomalies during infancy (OR 4.9, 95% CI 1.7–14.6). The lifetime prevalence of lymphatic anomalies was 37%. Genotype–phenotype correlations showed an especially high prevalence of lymphatic anomalies during infancy and childhood in patients with a pathogenic SOS2 variant (p = 0.03 and p &lt; 0.01, respectively). This study shows that patients with NS have a high predisposition for developing lymphatic anomalies during life. Especially patients with prenatal lymphatic anomalies have an increased risk of lymphatic anomalies during infancy. Genotype–phenotype correlations were found in pathogenic variants in SOS2.</description><identifier>ISSN: 1552-4825</identifier><identifier>EISSN: 1552-4833</identifier><identifier>DOI: 10.1002/ajmg.a.62955</identifier><identifier>PMID: 35979676</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley &amp; Sons, Inc</publisher><subject>Children ; Cohort analysis ; Female ; Genetic Association Studies ; Genotype ; Genotype &amp; phenotype ; Genotypes ; Humans ; lymphatic anomalies ; Lymphedema ; Medical records ; Noonan syndrome ; Noonan Syndrome - complications ; Noonan Syndrome - epidemiology ; Noonan Syndrome - genetics ; Noonan's syndrome ; Original ; Patients ; Phenotypes ; postnatal ; Pregnancy ; prenatal ; Retrospective Studies</subject><ispartof>American journal of medical genetics. Part A, 2022-11, Vol.188 (11), p.3242-3261</ispartof><rights>2022 The Authors. published by Wiley Periodicals LLC.</rights><rights>2022 The Authors. American Journal of Medical Genetics Part A published by Wiley Periodicals LLC.</rights><rights>2022. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4575-173ea3d12cd2b5b96052a6b0521cdcaa82d2f6fd4f11482219c3e6c10f73b1133</citedby><cites>FETCH-LOGICAL-c4575-173ea3d12cd2b5b96052a6b0521cdcaa82d2f6fd4f11482219c3e6c10f73b1133</cites><orcidid>0000-0003-4985-5782 ; 0000-0003-4829-6173 ; 0000-0002-0553-7064</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fajmg.a.62955$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fajmg.a.62955$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35979676$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Swarts, Jessie W.</creatorcontrib><creatorcontrib>Kleimeier, Lotte E. R.</creatorcontrib><creatorcontrib>Leenders, Erika K. S. M</creatorcontrib><creatorcontrib>Rinne, Tuula</creatorcontrib><creatorcontrib>Klein, Willemijn M.</creatorcontrib><creatorcontrib>Draaisma, Jos M. T.</creatorcontrib><title>Lymphatic anomalies during lifetime in patients with Noonan syndrome: Retrospective cohort study</title><title>American journal of medical genetics. Part A</title><addtitle>Am J Med Genet A</addtitle><description>Noonan syndrome (NS) has been associated with an increased risk of lymphatic anomalies, with an estimated prevalence of 20%. The prevalence of lymphatic anomalies seems to differ between pathogenic variants. Therefore, this study aims to describe the clinical presentation, prevalence and genotype–phenotype correlations of lymphatic anomalies during life in patients with NS. This retrospective cohort study included patients (n = 115) who were clinically and genetically diagnosed with NS and visited the Noonan expertise Center of the Radboud University Medical Center between January 2015 and March 2021. Data on lymphatic anomalies during lifetime were obtained from medical records. Lymphatic anomalies most often presented as an increased nuchal translucency, chylothorax and/or lymphedema. Prenatal lymphatic anomalies increased the risk of lymphatic anomalies during infancy (OR 4.9, 95% CI 1.7–14.6). The lifetime prevalence of lymphatic anomalies was 37%. Genotype–phenotype correlations showed an especially high prevalence of lymphatic anomalies during infancy and childhood in patients with a pathogenic SOS2 variant (p = 0.03 and p &lt; 0.01, respectively). This study shows that patients with NS have a high predisposition for developing lymphatic anomalies during life. Especially patients with prenatal lymphatic anomalies have an increased risk of lymphatic anomalies during infancy. Genotype–phenotype correlations were found in pathogenic variants in SOS2.</description><subject>Children</subject><subject>Cohort analysis</subject><subject>Female</subject><subject>Genetic Association Studies</subject><subject>Genotype</subject><subject>Genotype &amp; phenotype</subject><subject>Genotypes</subject><subject>Humans</subject><subject>lymphatic anomalies</subject><subject>Lymphedema</subject><subject>Medical records</subject><subject>Noonan syndrome</subject><subject>Noonan Syndrome - complications</subject><subject>Noonan Syndrome - epidemiology</subject><subject>Noonan Syndrome - genetics</subject><subject>Noonan's syndrome</subject><subject>Original</subject><subject>Patients</subject><subject>Phenotypes</subject><subject>postnatal</subject><subject>Pregnancy</subject><subject>prenatal</subject><subject>Retrospective Studies</subject><issn>1552-4825</issn><issn>1552-4833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>EIF</sourceid><recordid>eNp9kc1vFCEYh4nR2Np682xIvHhwVz4GmPFgsmnsh1k1MXpGBphdNjMwBabN_PfSbrtRD16AhCdP3t_7A-AVRkuMEHmvdsNmqZacNIw9AceYMbKoakqfHt6EHYEXKe0QoogJ_hwcUdaIhgt-DH6t52Hcquw0VD4Mqnc2QTNF5zewd53NbrDQeTgWxPqc4K3LW_g1BK88TLM3MQz2A_xucwxptDq7Gwt12IaYYcqTmU_Bs071yb58uE_Az_NPP84uF-tvF1dnq_VCV0ywBRbUKmow0Ya0rG04YkTxtpxYG61UTQzpeGeqDuOSiOBGU8s1Rp2gLcaUnoCPe-84tYM1ugwbVS_H6AYVZxmUk3__eLeVm3AjmxpVAjdF8PZBEMP1ZFOWg0va9r3yNkxJEoFoU1e0FgV98w-6C1P0JV6hCBEVJxUr1Ls9pctqUrTdYRiM5F118q46qeR9dQV__WeAA_zYVQGqPXDrejv_VyZXn79crPbe3-top7w</recordid><startdate>202211</startdate><enddate>202211</enddate><creator>Swarts, Jessie W.</creator><creator>Kleimeier, Lotte E. R.</creator><creator>Leenders, Erika K. S. M</creator><creator>Rinne, Tuula</creator><creator>Klein, Willemijn M.</creator><creator>Draaisma, Jos M. T.</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-4985-5782</orcidid><orcidid>https://orcid.org/0000-0003-4829-6173</orcidid><orcidid>https://orcid.org/0000-0002-0553-7064</orcidid></search><sort><creationdate>202211</creationdate><title>Lymphatic anomalies during lifetime in patients with Noonan syndrome: Retrospective cohort study</title><author>Swarts, Jessie W. ; Kleimeier, Lotte E. R. ; Leenders, Erika K. S. M ; Rinne, Tuula ; Klein, Willemijn M. ; Draaisma, Jos M. T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4575-173ea3d12cd2b5b96052a6b0521cdcaa82d2f6fd4f11482219c3e6c10f73b1133</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Children</topic><topic>Cohort analysis</topic><topic>Female</topic><topic>Genetic Association Studies</topic><topic>Genotype</topic><topic>Genotype &amp; phenotype</topic><topic>Genotypes</topic><topic>Humans</topic><topic>lymphatic anomalies</topic><topic>Lymphedema</topic><topic>Medical records</topic><topic>Noonan syndrome</topic><topic>Noonan Syndrome - complications</topic><topic>Noonan Syndrome - epidemiology</topic><topic>Noonan Syndrome - genetics</topic><topic>Noonan's syndrome</topic><topic>Original</topic><topic>Patients</topic><topic>Phenotypes</topic><topic>postnatal</topic><topic>Pregnancy</topic><topic>prenatal</topic><topic>Retrospective Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Swarts, Jessie W.</creatorcontrib><creatorcontrib>Kleimeier, Lotte E. R.</creatorcontrib><creatorcontrib>Leenders, Erika K. S. M</creatorcontrib><creatorcontrib>Rinne, Tuula</creatorcontrib><creatorcontrib>Klein, Willemijn M.</creatorcontrib><creatorcontrib>Draaisma, Jos M. T.</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of medical genetics. Part A</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Swarts, Jessie W.</au><au>Kleimeier, Lotte E. R.</au><au>Leenders, Erika K. S. M</au><au>Rinne, Tuula</au><au>Klein, Willemijn M.</au><au>Draaisma, Jos M. T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lymphatic anomalies during lifetime in patients with Noonan syndrome: Retrospective cohort study</atitle><jtitle>American journal of medical genetics. Part A</jtitle><addtitle>Am J Med Genet A</addtitle><date>2022-11</date><risdate>2022</risdate><volume>188</volume><issue>11</issue><spage>3242</spage><epage>3261</epage><pages>3242-3261</pages><issn>1552-4825</issn><eissn>1552-4833</eissn><abstract>Noonan syndrome (NS) has been associated with an increased risk of lymphatic anomalies, with an estimated prevalence of 20%. The prevalence of lymphatic anomalies seems to differ between pathogenic variants. Therefore, this study aims to describe the clinical presentation, prevalence and genotype–phenotype correlations of lymphatic anomalies during life in patients with NS. This retrospective cohort study included patients (n = 115) who were clinically and genetically diagnosed with NS and visited the Noonan expertise Center of the Radboud University Medical Center between January 2015 and March 2021. Data on lymphatic anomalies during lifetime were obtained from medical records. Lymphatic anomalies most often presented as an increased nuchal translucency, chylothorax and/or lymphedema. Prenatal lymphatic anomalies increased the risk of lymphatic anomalies during infancy (OR 4.9, 95% CI 1.7–14.6). The lifetime prevalence of lymphatic anomalies was 37%. Genotype–phenotype correlations showed an especially high prevalence of lymphatic anomalies during infancy and childhood in patients with a pathogenic SOS2 variant (p = 0.03 and p &lt; 0.01, respectively). This study shows that patients with NS have a high predisposition for developing lymphatic anomalies during life. Especially patients with prenatal lymphatic anomalies have an increased risk of lymphatic anomalies during infancy. Genotype–phenotype correlations were found in pathogenic variants in SOS2.</abstract><cop>Hoboken, USA</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>35979676</pmid><doi>10.1002/ajmg.a.62955</doi><tpages>20</tpages><orcidid>https://orcid.org/0000-0003-4985-5782</orcidid><orcidid>https://orcid.org/0000-0003-4829-6173</orcidid><orcidid>https://orcid.org/0000-0002-0553-7064</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1552-4825
ispartof American journal of medical genetics. Part A, 2022-11, Vol.188 (11), p.3242-3261
issn 1552-4825
1552-4833
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9804719
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Children
Cohort analysis
Female
Genetic Association Studies
Genotype
Genotype & phenotype
Genotypes
Humans
lymphatic anomalies
Lymphedema
Medical records
Noonan syndrome
Noonan Syndrome - complications
Noonan Syndrome - epidemiology
Noonan Syndrome - genetics
Noonan's syndrome
Original
Patients
Phenotypes
postnatal
Pregnancy
prenatal
Retrospective Studies
title Lymphatic anomalies during lifetime in patients with Noonan syndrome: Retrospective cohort study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T15%3A14%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lymphatic%20anomalies%20during%20lifetime%20in%20patients%20with%20Noonan%20syndrome:%20Retrospective%20cohort%20study&rft.jtitle=American%20journal%20of%20medical%20genetics.%20Part%20A&rft.au=Swarts,%20Jessie%20W.&rft.date=2022-11&rft.volume=188&rft.issue=11&rft.spage=3242&rft.epage=3261&rft.pages=3242-3261&rft.issn=1552-4825&rft.eissn=1552-4833&rft_id=info:doi/10.1002/ajmg.a.62955&rft_dat=%3Cproquest_pubme%3E2703984387%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2722746245&rft_id=info:pmid/35979676&rfr_iscdi=true